COVID Antibody: Zydus Cadila gets nod for ICMR-NIV developed ELISA kit

Published On 2020-05-16 08:05 GMT   |   Update On 2020-05-16 08:05 GMT
Advertisement

New Delhi: In a major breakthrough, drugmaker Zydus Cadila has received validation from the National Institute of Virology (NIV), Pune for the first batch of indigenous anti-SARS-CoV-2A (Covid-19) human IgG ELISA test kit for antibody detection of the lethal virus.

As per the Indian Council of Medical Research (ICMR), ELISA Kit has a similar sensitivity of 98.7 percent and specificity of 100 percent. The kit is cost-effective, sensitive, rapid and a large number of samples can be tested at any level of a clinical setting, including public health centers and hospitals. 

Advertisement

This comes days after the development of the technology at ICMR-NIV. The technology has been transferred to Zydus Cadila for mass production. Union Health Minister, Dr Harsh Vardhan confirmed the same through his social handle as;

As per a recent IANS report, the Council is in the process of carrying out a national surveillance study with 24,000 individuals.

As of now, 42 antibody-based rapid tests have been validated, and the following were found to be satisfactory. 10 of these kits are manufactured in India.

S.No.

Kit Detail

Lot no./Batch no.

1.

COVID-19 IgM IgG Rapid Test: BioMedomics (CE-IVD)

20200226

2.

New Coronavirus (COVID-19) IgG/IgM Rapid Test: Voxtur Bio Ltd, India

PCCV200301S

3.

COVID-19 IgM/IgG Antibody Detection Card Test: VANGUARD Diagnostics, India

RCOVID200301T

4.

Make sure COVID-19 Rapid test: HLL Lifecare Limited, India

CVCT030420

CVCT0204203 CVCT0104202

5.

YHLO iFlash-SARS-CoV-2 IgM and IgG detection kit (additional equipment required): CPC Diagnostics

20200206

6.

ACCUCARE IgM/IgG Lateral Flow Assay kit: LAB-CARE Diagnostics (India Pvt. Ltd)

CVC 200401

7.

Abchek COVID-19 IgM/IgG Antibody Rapid Test: NuLifecare

NUL/COV- 19/R&D/001

8.

One Step Corona Virus (COVID-19) IgM/IgG Antibody Test: ALPINE BIOMEDICALS

A10420

A20420

9.

COVID 19 IgM/IgG Rapid Test Kit; Medsource Ozone Biomedicals (ver 2.0)

COV-002

10.

Immuno Quick Rapid Test for Detection of Novel Coronavirus (COVID-19) IgM/IgG Antibodies: Immuno Science India Pvt. Ltd

E142001

11.

Standard Q COVID -19 IgM/IgG Duo test – One Step Rapid Antibody test: SD Biosensors

E054002

E054004

12.

COVID-19 IgG/IgM Rapid Test Kit Rafael Diagnostic: BMT Diagnostics

COV20030059

COV20030059-1

13.

One Step COVID-19 IgM/IgG Antibody: SIDAK Life Care Pvt. Ltd.

COVID19S004A

COVID19S004B

COVID19S004C

Rapid antibody tests are not recommended for diagnosis of COVID-19 infection

  •  Can be done on blood/serum/plasma samples

  •  The test result is available within 30 minutes

  •  The test may come positive after 7-10 days of infection

  •  The test may remain positive for several weeks after infection

  •  A positive test indicates exposure to SARS-CoV-2

  •  A negative test does not rule out COVID-19 infection

    These rapid antibody test kits have been validated in the laboratory. However, the performance of the kits may be subject to variation under field conditions. The above-listed kits are validated with the mentioned batch number only. Responsibility for the batch to batch, consistency lies with the manufacturer.

Guidance on rapid antibody kits for COVID-19

S.No.

Kit Detail

Lot no./Batch no.

14.

SARS-CoV-2 Antibody test (Lateral flow method): Guangzhou Wondfo Biotech,

Mylan Laboratories Limited (CE-IVD)
M R Roofs Private Ltd
Abbott Laboratories 

Zydus Cadila

#

W19500309

W19500302

W19500351

W19500338

15.

COVID-19 IgM/IgG Antibody Rapid Test: ZHUHAI LIVZON DIAGNOSTICS (CE- IVD)

# CK2003010410

# The marketing licenses to the distributors of these 2 companies have been canceled by the Central Drugs Standard Control Organization (CDSCO).

Antibody-based rapid tests which are CE-IVD approved

The complete list of CE-marked rapid SARS-CoV-2 antibody tests is available at (https://www.finddx.org/covid-19/pipeline/). CE-IVD approved kits can be used directly after due marketing approval from DCGI.

For the full details click on the following link:

https://medicaldialogues.in/pdf_upload/pdf_upload-128789.pdf

Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News